Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 2079

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 9A
Chunk 2079
---
 market access and expansion strategies in China. Cheryl has provided
consultations to both the U.S. and Chinese governments on pharmaceutical policies including strengthening of IP protection and monitoring
system for China’s API exports. Prior to that, she was the Director of International Finance at Pharmacia based in New Jersey from
1998 to 2003. Ms. Xu received her Bachelor of Science degree in Physics from Peking University, and Master of Business Administration
in Finance from Washington University in St. Louis. The Board concluded that Ms. Xu’s background and leadership experiences in
the pharmaceutical industry qualify her to be a member of the Board.

Dr. Stephen Toovey is one of our
directors since July 11, 2023 and is an infectious and tropical disease physician. Dr. Toovey has worked in the pharmaceutical industry
and academia in both developed and developing countries, and currently specializes in the research of influenza and other respiratory
viruses, malaria, rabies and the neurological aspects of infectious diseases. He is currently the Chief Executive Officer of Pegasus,
a medical and scientific services company and has held that position since 2008. Dr. Toovey also advises a number of pharmaceutical companies
and biotech organizations on infection and immunology related matters, from translation through Phase IV, and founded numerous pharmaceutical
and pharma-related companies, with the most recent being the co-founding of Ark Biosciences in 2014. Dr. Toovey served as Chief Medical
Officer of Ark Biosciences from 2014 until 2020. In addition, he held a teaching and clinical post at the Royal Free and University College
Medical School in London, United Kingdom, Academic Centre for Travel Medicine and Vaccines, World Health Organization Collaborating Center,
appointed in 2008. He has been editor of the journal Travel Medicine and Infectious Disease since its foundation in 2003. Dr. Toovey
has authored over 100 publications in peer reviewed medical journals, contributed to a number of textbooks and has presented at over
50 scientific meetings. Dr. Toovey received his PhD from the University of Ghent. The Board concluded that Dr. Toovey’s background
and leadership experiences in the pharmaceutical industry and academia qualify him to be a member of the Board.

Paul Field is one of our directors
since July 11, 2023. Paul has over 30 years of business development experience across a range of disease areas, and a deep network in
the global bioph